Puma Biotechnology Inc
Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) | Seeking Alpha
Alan H. Auerbach - Los Angeles Business Journal
PumaBiotech (@pumabiotech) / Twitter
Should You Buy Puma Biotechnology Inc (PBYI) Stock Tuesday?
Puma Biotechnology Surging
Puma Biotechnology - Updates, News, Events, Signals & Triggers
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer
Puma Biotechnology, Inc.
Here's Why Puma Biotechnology Fell 17.2% in April | The Motley Fool
Can Puma Biotechnology Inc (PBYI) Stock Rise to the Top of Healthcare Sector Tuesday?
Goldman Sachs Group Cuts Stake in Puma Biotechnology (PBYI)
Puma shares nearly triple on drug news, but options smell 'fishy'
Puma Biotechnology Announces Publication of Phase II Clinical Trial of Alisertib in JAMA Oncology | Business Wire
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | Business Wire
Puma (PBYI): Recent Rally Looks Overdone, Unsupported With Fundamentals | Seeking Alpha
Why Puma Biotechnology, Inc. Stock Crashed 37% in March | Fox Business
Puma Biotechnology falls more than 20%
Puma Biotechnology Executives Under Investigation for Breast Cancer Drug — Schubert Jonckheer & Kolbe
Former Puma Biotech executive gets U.S. prison term for insider trading | Reuters.com
Puma Biotechnology (PBYI) Stock Climbs On Orphan Drug Designation | Alpha Stock News
News Release
Puma Biotechnology Presents Final Results from the Biliary Tract Cohort of the Phase 2 SUMMIT 'Basket' Trial of Neratinib at the ASCO 2022 Annual Meeting | Business Wire
